MEMORANDUM OF UNDERSTANDING KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP") UPDATE ON MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN KANGER AND K-STAR SPORTS LIMITED ("K-STAR")
| KANGER INTERNATIONAL BERHAD |
| Type | Announcement |
| Subject | MEMORANDUM OF UNDERSTANDING |
| Description | KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP")
UPDATE ON MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN KANGER AND K-STAR SPORTS LIMITED ("K-STAR") |
|
Reference is made to the announcement dated 26 October 2020 pertaining to the MOU made between Kanger and K-Star for the purpose of appointing K-Star (or its subsidiary) as the sale agent of Covid-19 vaccines for the private clinics in Malaysia.
The Board of Directors of the Company wishes to announce that the Company is being allocated 10,000 doses of vaccines for trial purposes and will be getting approval from relevant authorities.
The first batch of vaccines is expected to arrive in May 2021.
This announcement is dated 9 March 2021. |
|
Announcement Info
| Company Name | KANGER INTERNATIONAL BERHAD |
| Stock Name | KANGER |
| Date Announced | 09 Mar 2021 |
| Category | General Announcement for PLC |
| Reference Number | GA1-08032021-00057 |